Cancer-related chronic pain: Investigation of the novel analgesic drug candidate cebranopadol in a randomized, double-blind, noninferiority trial

Cebranopadol, a novel first-in-class analgesic drug candidate

(2017) Annette Christoph et al.   PAIN

Persistent pain in cancer survivors

(2017) Elaine G. Boland et al.   Current Opinion in Supportive and Palliative Care

Pain prevalence in cancer patients

(2017) Johan Haumann et al.   Current Opinion in Supportive and Palliative Care

Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV ‘real life’ trial on the variability of response to opioids

(2016) O. Corli et al.   ANNALS OF ONCOLOGY

Cebranopadol: novel dual opioid/NOP receptor agonist analgesic

(2016) R. B. Raffa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis

(2016) Marieke H.J. van den Beuken-van Everdingen et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Sleep Disturbances in Patients With Advanced Cancer in Different Palliative Care Settings

(2015) Sebastiano Mercadante et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Discovery of a Potent Analgesic NOP and Opioid Receptor Agonist: Cebranopadol

(2014) Stefan Schunk et al.   ACS Medicinal Chemistry Letters

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC

(2012) Augusto Caraceni et al.   LANCET ONCOLOGY

Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

(2012) Freddie Bray et al.   LANCET ONCOLOGY

Treatment of cancer pain

(2011) Russell K Portenoy   LANCET

Importance of Side Effects in Opioid Treatment: A Trade-Off Analysis With Patients and Physicians

(2010) Razmic S. Gregorian et al.   JOURNAL OF PAIN

Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes

(2009) H. Breivik et al.   ANNALS OF ONCOLOGY